The increased expression of LYRM4 promoted malignant phenotypes of NSCLC cells via ferroptosis inhibition, which could explain why rs9606‐T allele contribute to increased risk of NSCLC. The gene discussed is LYRM4; the disease is non-small cell lung carcinoma.